New scan study aims to unlock Glioblastoma's metabolic secrets

NCT ID NCT06613841

First seen Jan 09, 2026 · Last updated May 15, 2026 · Updated 17 times

Summary

This pilot study will use two types of PET scans and a powerful 7Tesla MRI to create detailed metabolic profiles of glioblastoma, both in newly diagnosed and recurrent tumors. Researchers will compare the scan results with lab tests on tumor tissue to better understand how these aggressive brain cancers use energy. The goal is to gather knowledge that could guide future treatments, not to test a new therapy. About 15 adults with suspected or confirmed glioblastoma who are scheduled for surgery will participate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital of the University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.